Xenon Pharmaceuticals Inc.

Siren, L.L.C. XENE
Report date
12/31/2025
Quarter
2025 Q4
Filed
2/13/2026
Shares
812,761
Value ($000)
36,428
Weight
1.1%
2024 Q3 - 2025 Q4 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).